LP

Laurent POIROT

CE Cellectis: 36 patents #2 of 71Top 3%
AT Allogene Therapeutics: 1 patents #11 of 37Top 30%
Overall (All Time): #91,517 of 4,157,543Top 3%
36
Patents All Time

Issued Patents All Time

Showing 26–36 of 36 patents

Patent #TitleCo-InventorsDate
10765728 Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment Mathieu SIMON 2020-09-08
10584352 Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system Philippe Duchateau, Andre Choulika 2020-03-10
10517896 Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Roman Galetto, Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Andrew M. Scharenberg +1 more 2019-12-31
10472613 Method for modulating car-induced immune cells activity Philippe Duchateau, Alexandre Juillerat 2019-11-12
10426795 Use of preTalpha or functional variant thereof for expanding TCRalpha deficient T cells Roman Galetto, Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Andrew M. Scharenberg +1 more 2019-10-01
10363270 Methods for engineering allogeneic and immunosuppressive resistant T cell immunotherapy Roman Galetto, Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Andrew M. Scharenberg +1 more 2019-07-30
10286007 Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Roman Galetto, Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Andrew M. Scharenberg +1 more 2019-05-14
10239948 Method of engineering multi-input signal sensitive T cell for immunotherapy Alexandre Juillerat, Claudia Bertonati, Julien Valton, Philippe Duchateau 2019-03-26
10196608 Method for in situ inhibition of regulatory T cells Philippe Duchateau 2019-02-05
9890393 Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system Philippe Duchateau, Andre Choulika 2018-02-13
9855297 Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system Philippe Duchateau, Andre Choulika 2018-01-02